Vanderbilt University's venture capital investment strategy, managed through its diversified endowment, focuses on long-term partnerships with world-class managers and includes being an early institutional investor in venture capital. Additionally, the Vanderbilt Venture Partners (VVP) program specifically targets early-stage (seed and Series A) startups from Vanderbilt's research, aiming to commercialize scientific innovations and often being the first institutional investor in unique opportunities.
They made 5 investments in the last 12 months. Their most common stage is series-b (50% of deals). Average disclosed round size is $48.0M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$10.3B
Top Stage
Series B
Last 12 Mo
5
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| CCambium Biomaterials | Series B | $100M | Jan 2026 |
 Cambium | Series B | $100M | Jan 2026 |
 Arcturus | Seed | $2.3M | Dec 2025 |
 Foundation Health | Series A | $20M | Oct 2025 |
 Zeno Power | Series B | $50M | May 2025 |
| BBackpackr | Series C | $16M | Jan 2023 |
Top Co-Investors
Last updated: 16 April 2026